CN Patent

CN105193799A — 使用经口因子xa抑制剂治疗血栓形成的单位剂量调配物和方法

Assigned to Millennium Pharmaceuticals Inc · Expires 2015-12-30 · 10y expired

What this patent protects

本申请涉及使用经口因子XA抑制剂治疗血栓形成的单位剂量调配物和方法。在灵长类动物中抑制凝血所需的本文所揭示的因子Xa抑制剂化合物的单位剂量比在其它动物模型(诸如，啮齿动物)中获得类似凝血抑制程度所需的单位剂量低。本文还教示适用于预测人类活体内抗血栓形成活性的活体外检定。

USPTO Abstract

本申请涉及使用经口因子XA抑制剂治疗血栓形成的单位剂量调配物和方法。在灵长类动物中抑制凝血所需的本文所揭示的因子Xa抑制剂化合物的单位剂量比在其它动物模型(诸如，啮齿动物)中获得类似凝血抑制程度所需的单位剂量低。本文还教示适用于预测人类活体内抗血栓形成活性的活体外检定。

Drugs covered by this patent

Patent Metadata

Patent number
CN105193799A
Jurisdiction
CN
Classification
—
Expires
2015-12-30
Drug substance claim
No
Drug product claim
No
Assignee
Millennium Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.